Compared to currently approved drugs prescribed for the treatment of Alzheimer’s disease, THC is a considerably superior inhibitor of Abeta aggregation, and this study provides a previously unrecognized molecular mechanism through which cannabinoid molecules may directly impact the progression of this debilitating disease.
Can Pot Defeat Alzhiemer’s? | PubMed.gov
~ CBPS
Published by CBPS
Peter Mehit is co-founder and Managing Partner of Custom Business Planning and Solutions, a business consulting firm that provides problem solving, planning and process help. He has worked from private equity to the Fortune 100 at all stages. He can be reached at pmehit@wbpllc.com or at 800-741-8444. View all posts by CBPS
Dispatches From The Front 